Paper41739723
Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022.
Costa JCB and 2 others. Epidemiol Serv Saude, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022. Papers, record 41739723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41739723
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Health Care Costs | Major topic |
| Hospitalization | Major topic |
| Humans | |
| Female | |
| Male | |
| Cohort Studies | |
| Referral and Consultation | |
| Brazil | |
| Child | |
| Adolescent | |
| Delayed Diagnosis | |
| Early Diagnosis | |
| Child, Preschool | |
| Adult | |
| Follow-Up Studies | |
| Young Adult | |
| Infant |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22690685 | Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre. | Pharmacoeconomics | 2012 | https://conductscience.org/library/papers/22690685 | PubMed |
| 2 | 26743971 | Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study. | Eur J Health Econ | 2017 | https://conductscience.org/library/papers/26743971 | PubMed |
| 3 | 30949989 | The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective. | Pharmacoeconomics | 2019 | https://conductscience.org/library/papers/30949989 | PubMed |
| 4 | 40396435 | Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France. | Pediatr Pulmonol | 2025 | https://conductscience.org/library/papers/40396435 | PubMed |
| 5 | 16202771 | Assessing the cost of cystic fibrosis diagnosis and treatment. | J Pediatr | 2005 | https://conductscience.org/library/papers/16202771 | PubMed |
| 6 | 29439099 | Addressing the Root Cause: Rising Health Care Costs and Social Determinants of Health. | N C Med J | 2018 | https://conductscience.org/library/papers/29439099 | PubMed |
| 7 | 23538187 | Understanding the costs of care for cystic fibrosis: an analysis by age and health state. | Value Health | 2013 | https://conductscience.org/library/papers/23538187 | PubMed |
| 8 | 36849331 | Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. | J Cyst Fibros | 2023 | https://conductscience.org/library/papers/36849331 | PubMed |
| 9 | 28129811 | Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. | J Pediatr | 2017 | https://conductscience.org/library/papers/28129811 | PubMed |
| 10 | 27896782 | Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group. | Health Econ Rev | 2016 | https://conductscience.org/library/papers/27896782 | PubMed |
| 11 | 27118577 | The benefits of newborn screening for cystic fibrosis: The Canadian experience. | J Cyst Fibros | 2016 | https://conductscience.org/library/papers/27118577 | PubMed |
| 12 | 32172930 | Variant classifications, databases and genotype-phenotype correlations. | Arch Pediatr | 2020 | https://conductscience.org/library/papers/32172930 | PubMed |
| 13 | 11865265 | Cystic fibrosis: a 2002 update. | J Pediatr | 2002 | https://conductscience.org/library/papers/11865265 | PubMed |
| 14 | 27140670 | Cystic fibrosis. | Lancet | 2016 | https://conductscience.org/library/papers/27140670 | PubMed |
| 15 | 35679883 | Five-year performance analysis of a cystic fibrosis newborn screening program in northeastern Brazil. | J Pediatr (Rio J) | 2023 | https://conductscience.org/library/papers/35679883 | PubMed |
| 16 | 22433759 | Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial. | Value Health | 2012 | https://conductscience.org/library/papers/22433759 | PubMed |
| 17 | 39122474 | Socioeconomic burden of cystic fibrosis in Canada. | BMJ Open Respir Res | 2024 | https://conductscience.org/library/papers/39122474 | PubMed |
| 18 | 17002482 | Hospitalisation costs of cystic fibrosis. | Pharmacoeconomics | 2006 | https://conductscience.org/library/papers/17002482 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41739723
GET https://conductscience.org/api/papers/v1/41739723/authors